{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:41:16Z","timestamp":1792082476569,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":101,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007938.pub2","type":"reference-entry","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T23:11:23Z","timestamp":1299712283000},"source":"Crossref","is-referenced-by-count":91,"title":["Gabapentin for chronic neuropathic pain and fibromyalgia in adults"],"prefix":"10.1002","author":[{"given":"R Andrew","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J","family":"McQuay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD007938.pub2-BIB3|cit2","unstructured":"Trial summary - Parke Davis\/Pfizer 945-210 Unpublished report"},{"issue":"21","key":"10.1002\/14651858.CD007938.pub2-BIB2|cit3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub2-BIB4|cit4","first-page":"481","article-title":"Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study","volume":"27","author":"Bone","year":"2002","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"14","key":"10.1002\/14651858.CD007938.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group","volume":"22","author":"Caraceni","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD007938.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CPP44358","article-title":"Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial - the GONIP Trial","volume":"44","author":"Chandra","year":"2006","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD007938.pub2-BIB7|cit7","unstructured":"Anon Protocol A9451008. A 15 Week, randomized, double-blind, placebo-controlled, parallel-group, multi-center study of Neurontin (gabapentin) for efficacy and quality of life in patients with painful diabetic peripheral neuropathy PhrmaWebSynopsis - Final"},{"key":"10.1002\/14651858.CD007938.pub2-BIB8|cit8","unstructured":"Protocol 945-224. A double-blind placebo-controlled trial With 3 doses of gabapentin for treatment of painful diabetic peripheral neuropathy. May 29, 1998 through September 7, 1999 Unpublished"},{"issue":"13","key":"10.1002\/14651858.CD007938.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"9697","key":"10.1002\/14651858.CD007938.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pain.2007.12.011","article-title":"Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study","volume":"138","author":"Gordh","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp.66.2.251","article-title":"Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial","volume":"66","author":"Gorson","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","article-title":"A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies","volume":"251","author":"Hahn","year":"2004","journal-title":"Journal of Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pain.2008.07.013","article-title":"Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies","volume":"14","author":"Ho","year":"2009","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AJP.0b013e3181934276","article-title":"Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial","volume":"25","author":"Irving","year":"2009","journal-title":"Clinical Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/AJP.0b013e318192bf87","article-title":"Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia","volume":"25","author":"Jensen","year":"2009","journal-title":"Clinical Journal of Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pain.2006.08.028","article-title":"Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial","volume":"127","author":"Kimos","year":"2007","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.BRS.0000112068.16108.3A","article-title":"Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury","volume":"29","author":"Levendoglu","year":"2004","journal-title":"Spine"},{"issue":"16","key":"10.1002\/14651858.CD007938.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007938.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9343(00)00398-3","article-title":"Gabapentin therapy for diabetic neuropathic pain","volume":"108","author":"Perez","year":"2000","journal-title":"Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","article-title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)","volume":"110","author":"Rao","year":"2007","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD007938.pub2-BIB23|cit22","unstructured":"Study detail and analysis, Parke-Davis 945-295 Unpublished Report No. RR-430-00124 2000"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB22|cit23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala","year":"2007","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD007938.pub2-BIB25|cit25","unstructured":"Detailed summary, study No.4, Parke-Davis 945-211 Unpublished Report No. RR-995-00070 1998"},{"issue":"21","key":"10.1002\/14651858.CD007938.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2337\/dc08-1450","article-title":"Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial","volume":"32","author":"Sandercock","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007938.pub2-BIB28|cit28","unstructured":"Parke Davis\/Pfizer 945-430-306 Unpublished 2000"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Serpell","year":"2002","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1682\/JRRD.2005.05.0082","article-title":"Efficacy of gabapentin in treating chronic phantom limb and residual limb pain","volume":"42","author":"Smith","year":"2005","journal-title":"Journal of Rehabilitation Research and Development"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10790268.2002.11753609","article-title":"Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial","volume":"25","author":"Tai","year":"2002","journal-title":"Journal of Spinal Cord Medicine"},{"key":"10.1002\/14651858.CD007938.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2377-4-13","article-title":"Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]","volume":"4","author":"Vusse","year":"2004","journal-title":"BMC Neurology"},{"issue":"11","key":"10.1002\/14651858.CD007938.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11539520-000000000-00000","article-title":"Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"30","author":"Wallace","year":"2010","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00540-010-0913-6","article-title":"Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine","volume":"24","author":"Arai","year":"2010","journal-title":"Journal of Anesthesia"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/01.WNL.0000168259.94991.8a","article-title":"A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster","volume":"65","author":"Berry","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0885-3924(00)00181-0","article-title":"Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study","volume":"20","author":"Dallocchio","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2008.12.022","article-title":"A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster","volume":"142","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB39|cit39","first-page":"73","article-title":"Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study","volume":"43","author":"Jean","year":"2005","journal-title":"Acta Anaesthesiologica Taiwan"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpainsymman.2006.11.013","article-title":"Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial","volume":"34","author":"Keskinbora","year":"2007","journal-title":"Journal of Pain Symptom Management"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1464-5491.2010.03054.x","article-title":"Comparison of the efficacy and safety of tramadol\/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy","volume":"27","author":"Ko","year":"2010","journal-title":"Diabetes Medicine"},{"key":"10.1002\/14651858.CD007938.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1163\/156856901753420945","article-title":"Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study","volume":"13","author":"McCleane","year":"2001","journal-title":"The Pain Clinic"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00000542-200611000-00023","article-title":"A randomized study of the effects of gabapentin on postamputation pain","volume":"105","author":"Nikolajsen","year":"2006","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","article-title":"Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blinded, placebo-controlled, crossover study","volume":"95","author":"Pandey","year":"2002","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","article-title":"The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit","volume":"101","author":"Pandey","year":"2005","journal-title":"Anesthesia and Analgesia"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1526-4637.2008.00515.x","article-title":"Facial pain: a possible therapy with stellate ganglion block","volume":"9","author":"Salvaggio","year":"2008","journal-title":"Pain Medicine"},{"issue":"21-22","key":"10.1002\/14651858.CD007938.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00508-005-0464-2","article-title":"Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study","volume":"117","author":"Sator-Katzenschlager","year":"2005","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.brs.0000261029.29170.e6","article-title":"The efficiency of gabapentin therapy in patients with lumbar spinal stenosis","volume":"32","author":"Yaksi","year":"2007","journal-title":"Spine"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1526-4637.2009.00615.x","article-title":"N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain","volume":"10","author":"Yelland","year":"2009","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1163\/156856903767650718","article-title":"The effectiveness of gabapentin in patients with chronic radiculopathy","volume":"15","author":"Yildirim","year":"2003","journal-title":"The Pain Clinic"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11606-008-0877-5","article-title":"Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials","volume":"24","author":"Chou","year":"2009","journal-title":"Journal of General Internal Medicine"},{"issue":"6977","key":"10.1002\/14651858.CD007938.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0885-3924(00)00181-0","article-title":"Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study","volume":"20","author":"Dallocchio","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007938.pub2-BIB59|cit59","unstructured":"Electronic Medicines Compendium http:\/\/emc.medicines.org.uk\/"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin - a meta-analysis of randomized controlled trials","volume":"145","author":"Ha\u00fcser","year":"2009","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status 3 and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub2-BIB67|cit67","volume-title":"Management of cancer pain. Clinical Practice Guideline No. 9. Agency for Health Care Policy and Research","author":"Jacox","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007938.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMp0808659","article-title":"The Neurontin legacy - marketing through misinformation and manipulation","volume":"360","author":"Landefeld","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB72|cit72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007115.pub2","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7012","key":"10.1002\/14651858.CD007938.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007938.pub2-BIB74|cit74","article-title":"An evidence-based resource for pain relief","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub2-BIB76|cit76","first-page":"963","article-title":"Psychotropic drugs","volume-title":"Textbook of Pain","author":"Monks","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.pain.2005.05.001","article-title":"Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results","volume":"116","author":"Moore","year":"2005","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"R644","DOI":"10.1186\/ar1704","article-title":"Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Research and Therapy"},{"key":"10.1002\/14651858.CD007938.pub2-BIB80|cit80","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB81|cit81","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007938","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007938.pub2-BIB82|cit82","first-page":"http:\/\/ard.bmj.","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"[Epub ahead of","author":"Moore","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD007938.pub2-BIB83|cit83","first-page":"Epub ahead of p","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"Sep 10","author":"Moore","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pain.2010.02.032","article-title":"Topical review: chronic low back pain analgesic studies - a methodological minefield","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007938.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment: outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-3959(02)00024-6","article-title":"Pharmacological treatments for acute migraine: quantitative systematic review","volume":"97","author":"Oldman","year":"2002","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub2-BIB91|cit91","unstructured":"Perry T Neurontin - expert opinion on efficacy and effectiveness for pain http:\/\/dida.library.ucsf.edu\/tid\/oxx18p10 2008"},{"key":"10.1002\/14651858.CD007938.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-9-6","article-title":"Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain","volume":"9","author":"Quilici","year":"2009","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub2-BIB94|cit94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008183.pub2","article-title":"Single dose oral gabapentin for established acute postoperative pain in adults","author":"Straube","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007938.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00228-008-0523-5","article-title":"Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature","volume":"64","author":"Tzellos","year":"2008","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"20","key":"10.1002\/14651858.CD007938.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMsa0906126","article-title":"Outcome reporting in industry-sponsored trials of gabapentin for off-label use","volume":"361","author":"Vedula","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub2-BIB99|cit99","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub2-BIB100|cit100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006044.pub3","article-title":"Withdrawn - Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub2-BIB101|cit101","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"Carbamazepine for acute and chronic pain","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007938.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T02:47:40Z","timestamp":1712285260000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007938.pub2"}},"subtitle":[],"editor":[{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":101,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007938.pub2","relation":{},"subject":[],"published":{"date-parts":[[2011,3,16]]}}}